187 related articles for article (PubMed ID: 21696712)
1. Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.
Podojil JR; Padval MV; Miller SD
Cell Immunol; 2011; 270(2):237-50. PubMed ID: 21696712
[TBL] [Abstract][Full Text] [Related]
2. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
[TBL] [Abstract][Full Text] [Related]
3. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
Imler TJ; Petro TM
Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
[TBL] [Abstract][Full Text] [Related]
4. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
[TBL] [Abstract][Full Text] [Related]
5. Male SJL mice do not relapse after induction of EAE with PLP 139-151.
Bebo BF; Vandenbark AA; Offner H
J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079
[TBL] [Abstract][Full Text] [Related]
6. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
[TBL] [Abstract][Full Text] [Related]
7. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
[TBL] [Abstract][Full Text] [Related]
8. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
Nath N; Giri S; Prasad R; Salem ML; Singh AK; Singh I
J Immunol; 2005 Jul; 175(1):566-74. PubMed ID: 15972693
[TBL] [Abstract][Full Text] [Related]
9. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
10. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells.
Kuhns MS; Epshteyn V; Sobel RA; Allison JP
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12711-6. PubMed ID: 11050166
[TBL] [Abstract][Full Text] [Related]
12. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms.
Podojil JR; Liu LN; Marshall SA; Chiang MY; Goings GE; Chen L; Langermann S; Miller SD
J Autoimmun; 2013 Aug; 44():71-81. PubMed ID: 23683881
[TBL] [Abstract][Full Text] [Related]
13. Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis.
Bebo BF; Zelinka-Vincent E; Adamus G; Amundson D; Vandenbark AA; Offner H
J Neuroimmunol; 1998 Apr; 84(2):122-30. PubMed ID: 9628453
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice.
Hofstetter HH; Toyka KV; Tary-Lehmann M; Lehmann PV
J Immunol; 2007 Feb; 178(3):1372-8. PubMed ID: 17237384
[TBL] [Abstract][Full Text] [Related]
15. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
17. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.
Natarajan C; Bright JJ
J Immunol; 2002 Jun; 168(12):6506-13. PubMed ID: 12055272
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.
Podojil JR; Kohm AP; Miller SD
J Immunol; 2006 Sep; 177(5):2948-58. PubMed ID: 16920930
[TBL] [Abstract][Full Text] [Related]
20. Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males.
Matarese G; Sanna V; Di Giacomo A; Lord GM; Howard JK; Bloom SR; Lechler RI; Fontana S; Zappacosta S
Eur J Immunol; 2001 May; 31(5):1324-32. PubMed ID: 11465089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
